BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 32508053)

  • 21. Validation of the 8
    Zhou J; Lei J; Wang J; Lian CL; Hua L; Yang LC; Wu SG
    Aging (Albany NY); 2020 Apr; 12(8):7549-7560. PubMed ID: 32320950
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The 8th edition of the American Joint Committee on Cancer staging system provide improved prognostic accuracy in T1-2N1M0 postmastectomy breast cancer patients].
    Sun GY; Wang SL; Tang Y; Yang Y; Fang H; Wang JY; Jing H; Zhang JH; Jin J; Song YW; Liu YP; Chen B; Qi SN; Li N; Tang Y; Lu NN; Wang WH; Chen SY; Ren H; Liu XF; Yu ZH; Li YX
    Zhonghua Zhong Liu Za Zhi; 2019 Aug; 41(8):615-623. PubMed ID: 31434454
    [No Abstract]   [Full Text] [Related]  

  • 23. A retrospective prognostic evaluation analysis using the 8th edition of American Joint Committee on Cancer (AJCC) cancer staging system for luminal A breast cancer.
    Ye J; Wang W; Xu L; Duan X; Cheng Y; Xin L; Zhang H; Zhang S; Li T; Liu Y
    Chin J Cancer Res; 2017 Aug; 29(4):351-360. PubMed ID: 28947867
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The role of postmastectomy radiotherapy in clinical T1-3N1M0 breast cancer patients with pathological negative lymph nodes after neoadjuvant chemotherapy and mastectomy].
    Rong QL; Wang SL; Tang Y; Jin J; Song YW; Wang WH; Liu YP; Fang H; Ren H; Liu XF; Yu ZH; Li YX
    Zhonghua Zhong Liu Za Zhi; 2017 Jun; 39(6):445-452. PubMed ID: 28635235
    [No Abstract]   [Full Text] [Related]  

  • 25. Integration the biologic factors into the staging of breast cancer patients with ipsilateral supraclavicular lymph node metastasis.
    Lian CL; Cai XY; Zhou P; Wang J; Chen XB; Wu SG
    J Cancer; 2020; 11(23):6834-6840. PubMed ID: 33123274
    [No Abstract]   [Full Text] [Related]  

  • 26. The prognostic differences and the effect of postmastectomy radiotherapy between post-chemotherapy ypT1-2ypN1 and de novo pT1-2N1 breast cancer.
    Yang T; Zhong X; Wang J; Xiang Z; Zeng Y; Yu S; Dai Z; Xu N; Luo T; Liu L
    Cancer Med; 2023 Apr; 12(7):8112-8121. PubMed ID: 36734308
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Local-regional recurrence with and without radiation therapy after neoadjuvant chemotherapy and mastectomy for clinically staged T3N0 breast cancer.
    Nagar H; Mittendorf EA; Strom EA; Perkins GH; Oh JL; Tereffe W; Woodward WA; Gonzalez-Angulo AM; Hunt KK; Buchholz TA; Yu TK
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(3):782-7. PubMed ID: 21885207
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Practical Model to Optimize the Strategy of Adjuvant Postmastectomy Radiotherapy in T1-2N1 Breast Cancer With Modern Systemic Therapy.
    Xu FF; Cao L; Xu C; Cai G; Wang SB; Qi WX; Chen JY
    Front Oncol; 2022; 12():789198. PubMed ID: 35280719
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of pathologic stages on postmastectomy radiation therapy in breast cancer receiving neoadjuvant chemotherapy and total mastectomy: A Cancer Database Analysis.
    Zhang J; Lu CY; Chen CH; Chen HM; Wu SY
    Breast; 2020 Dec; 54():70-78. PubMed ID: 32947148
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nomogram-Based Risk Stratification to Identify Patients with T3N0M0 Breast Cancer with Survival Benefit from Postmastectomy Radiotherapy.
    Meng X; Wang N; Qin P; Jia Q; Ju Z; Jiang Y
    Ann Surg Oncol; 2024 Mar; 31(3):1634-1642. PubMed ID: 38087136
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mesenterico-portal vein invasion should be an important factor in TNM staging for pancreatic ductal adenocarcinoma: Proposed modification of the 8
    Chen HY; Wang X; Zhang H; Liu XB; Tan CL
    World J Gastroenterol; 2019 Dec; 25(46):6752-6766. PubMed ID: 31857777
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Incorporating Tumor Characteristics to the American Joint Committee on Cancer Breast Cancer Staging System.
    Chavez-MacGregor M; Mittendorf EA; Clarke CA; Lichtensztajn DY; Hunt KK; Giordano SH
    Oncologist; 2017 Nov; 22(11):1292-1300. PubMed ID: 28592619
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Survival Comparisons between Breast Conservation Surgery and Mastectomy Followed by Postoperative Radiotherapy in Stage I-III Breast Cancer Patients: Analysis of the Surveillance, Epidemiology, and End Results (Seer) Program Database.
    Xiang W; Wu C; Wu H; Fang S; Liu N; Yu H
    Curr Oncol; 2022 Aug; 29(8):5731-5747. PubMed ID: 36005190
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Validation of the Prognostic Significance of the Prognostic Stage Group According to the Eighth Edition of American Cancer Joint Committee on Cancer Staging System in Triple-Negative Breast Cancer: An Analysis From Surveillance, Epidemiology, and End Results 18 Database.
    Luo SP; Wu QS; Chen H; Wang XX; Chen QX; Zhang J; Song CG
    J Surg Res; 2020 Mar; 247():211-219. PubMed ID: 31706539
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Validation of the new AJCC eighth edition of the TNM classification for breast cancer with a single-center breast cancer cohort.
    Kim JY; Lim JE; Jung HH; Cho SY; Cho EY; Lee SK; Yu JH; Lee JE; Kim SW; Nam SJ; Park YH; Ahn JS; Im YH
    Breast Cancer Res Treat; 2018 Oct; 171(3):737-745. PubMed ID: 29931426
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of postmastectomy radiotherapy on T1-2N1M0 triple-negative breast cancer.
    Xia LY; Xu WY; Zhao Y
    PLoS One; 2022; 17(6):e0270528. PubMed ID: 35749525
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Postmastectomy radiation therapy for T3N0: a SEER analysis.
    Johnson ME; Handorf EA; Martin JM; Hayes SB
    Cancer; 2014 Nov; 120(22):3569-74. PubMed ID: 24985911
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Post-mastectomy radiotherapy is associated with improved overall survival in T3N0 patients who do not receive chemotherapy.
    Almahariq MF; Quinn TJ; Siddiqui ZA; Thompson AB; Jawad MS; Chen PY; Gustafson GS; Dilworth JT
    Radiother Oncol; 2020 Apr; 145():229-237. PubMed ID: 32065903
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of the AJCC Eighth-Edition Prognostic Staging System for Breast Cancer in a Latin American Cohort.
    Cervera-Bonilla S; Rodríguez-Ossa P; Vallejo-Ortega M; Osorio-Ruiz A; Mendoza-Diaz S; Orozco-Ospino M; Lehmann-Mosquera C; Duarte-Torres C; Ángel-Aristizábal J; Guzmán-Abisaab L; Garcia-Mora M; Diaz-Casas S
    Ann Surg Oncol; 2021 Oct; 28(11):6014-6021. PubMed ID: 33830356
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adjuvant Radiation Therapy for T3N0 Breast Cancer Patients Older Than 75 Years After Mastectomy: A SEER Analysis.
    Chen J; Wu X; Christos P; Yan W; Ravi A
    Clin Breast Cancer; 2018 Oct; 18(5):e967-e973. PubMed ID: 29914691
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.